Company Profiles
Since 1953, SERVA has been a supplier to the biochemistry research market. Collagenase NB for tissue dissociation, now a main product, is suitable for the isolation of many cell types from various species. Pharmaceutical manufacturing standard implies high lot-to-lot consistency and safety. Superior quality guarantees cell viability and high yields. SERVA is established as a worldwide supplier of GMP Collagenase for isolation of different cell types for transplantation into humans. In 2009 a DMF was filed with the FDA for Collagenase NB 1 GMP Grade and Neutral Protease NB GMP Grade.
CellGenix GmbH, a German biopharmaceutical company, operates a state-of-the-art GMP facility for cell processing and GMP production of recombinant biopharmaceuticals. CellGenix develops, manufactures and markets high quality cell processing tools for clinical cell therapy: GMP-grade cytokines, Serum-free media and culture bags for the cultivation of dendritic cells, hematopoietic stem cells, T-cells and NK-cells.
PeproTech was established in 1988 to provide life science research with the highest quality cytokine products at the most competitive prices. Today, PeproTech is a world leader in supplying high quality cytokine products including E. coli, insect, and mammalian cell-derived recombinant proteins, their monoclonal/polyclonal antibodies, ELISA development kits, and other cytokine-related reagents. Our most recent developments include a range of animal-free recombinant proteins and serum-free media supplement kits.
As a manufacturer PeproTech provides the highest level of technical support and customer service. We offer pack sizes ranging from microgram to milligram quantities, and a custom vialing service is available to provide maximum flexibility to our customers. PeproTech is constantly striving to better meet the needs of our customers and therefore welcome any feedback.
GE Healthcare Life Sciences delivers breakthroughs in drug discovery, biopharmaceutical manufacturing and the latest in cellular technologies, so scientists and specialists around the world discover new ways to predict, diagnose and treat disease. For more information about GE Healthcare Life Sciences, visit our website at www.gelifesciences.com.
Bionicor
Bionicor Innovations was founded in the year 2009 and focuses on development, manufacturing and distribution of heart valves which have been optimized for colonization with stem cells. Further corporate purpose is the development and market launch of corresponding technologies, especially the development of medical devices for the vascular, particularly the cardiovascular area for intraoperative stem cell therapy.
LifeStar Institute is an extraordinary collaboration to identify barriers to the development and distribution of technologies able to preserve and restore function in already mature individuals. Scientists, policy-makers, health professionals, economists, demographers, ethicists, and more, all come together to create a strategy to answer the challenge and threat of a globally aging population. http://www.lifestarinstitute.org
Huss
Ralf Huss
Prof. Dr. Dr. h.c. Ralf Huss is Vice President for Pharma Development at Roche Diagnostics GmbH, Penzberg.
Brand
Michael Brand
Director of the Biotechnology Center, Technical University Dresden, and Director, DFG FG Center for Regenerative Therapies Dresden
Su
Henry Chen-Yao Su
Professor and Head of the Biomedical Research Unit, Department of Dentistry, National Yang-Ming University Taipei, Taiwan
Bartolo
Loredana De Bartolo
Ph.D. Loredana De Bartolo is Group Leader at the Institute on Membrane Technology, ITM-CNR, Italy.